CLEVELAND - Sept. 13, 2018 - TelAve -- Recognizing the lack of funding for pediatric medical device development, PediaVascular held a product pitch competition during the Pediatric & Adult Interventional Cardiac Symposium on September 6, in Las Vegas. Five teams of pediatric cardiologists presented their concepts to a panel of interventional cardiology experts. The winning concept was titled Deflectable Hybrid Sheath from a team at Our Lady's Children's Hospital in Crumlin, Ireland. PediaVascular awarded the team an unrestricted $25,000 grant to continue development efforts. The award also included complimentary consultations with regulatory, reimbursement, intellectual property, legal and business experts to assist in product commercialization.

More on TelAve News

• $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
• Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
• Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
• Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
• Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings

About PediaVascular: PediaVascular is a social venture formed in 2010 to address the lack of pediatric medical devices. In collaboration with fifty pediatric cardiologists PediaVascular developed a series of angiography catheters, introducers and guide wires specifically for children. They are the first and only to receive FDA clearance for pediatric use. To date, over 15,000 babies have been treated globally with PediaVascular's devices.

http://www.pediavascular.com